Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
about
Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden ThreatHorizontal Transfer of Carbapenemase-Encoding Plasmids and Comparison with Hospital Epidemiology DataLeveraging antimicrobial stewardship into improving rates of carbapenem-resistant EnterobacteriaceaeNecrotizing fasciitis caused by hypermucoviscous Klebsiella pneumoniae in a Filipino female in North America.Overexpression of an outer membrane protein associated with decreased susceptibility to carbapenems in Proteus mirabilisAcinetobacter calcoaceticus from a fatal case of pneumonia harboring bla(NDM-1) on a widely distributed plasmid.Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in AsiaFour Cases of Carbapenem-Resistant Enterobacteriaceae Infection from January to March in 2014.High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strainsEnhancing and initiating phage-based therapies.Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniaeThe ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress.A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical CharacteristicsIntestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance MethodsEfficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of DefensePrevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?Identification of Klebsiella pneumoniae Carbapenemase-producing Klebsiella oxytoca in Clinical Isolates in Tehran Hospitals, Iran by Chromogenic Medium and Molecular Methods.Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE).Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium.Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae elucidated by single-nucleotide variation analysis: a case investigation.Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.Draft Genome Sequence of a New Delhi Metallo-β-Lactamase-5 (NDM-5)-Producing Multidrug-Resistant Escherichia coli IsolateCarba NP as a simpler, rapid, cost-effective, and a more sensitive alternative to other phenotypic tests for detection of carbapenem resistance in routine diagnostic laboratoriesGenome Sequence of Klebsiella pneumoniae Urinary Tract Isolate Top52.Carbapenem Resistance: A Review.Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia.Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).Food-animal production and the spread of antibiotic resistance: the role of ecologyMolecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China
P2860
Q26751295-CED51250-AF7A-4EF2-9622-47F639EC8FF6Q30276648-1FEEB0C8-887E-4939-B20A-1E72984FC368Q33816217-28E8D6C8-CD3E-4157-88E0-39226AA69EBAQ35017885-D15E03B5-B3A5-4B03-AE4D-A9BB99D3C0AFQ35165008-38923BBF-3FF4-4368-9724-5372106DB7C3Q35216500-BBC51389-567E-4EDB-87C1-0E882E4593D0Q35290820-49D43B92-64FF-459E-ADEB-85BB15004BD6Q35890464-7D83C12F-B68A-4F5F-802E-96FF11B9B201Q35993023-DF09FDD8-022D-47BC-BA07-E56FD4C8AC89Q36097659-F0EE5FAB-B438-4C97-824F-923F88786A07Q36105880-360646EE-72D0-473C-AD13-35987FACE3C4Q36131744-FBC8799C-5ABE-4084-949D-35A62EAD57D0Q36274141-FE1F0775-4A63-4097-96A7-E7FD81B02567Q36388444-50EFB6B1-1AA1-455C-8BE4-C2436912F10FQ36438958-7A056540-4ADE-4036-A68A-1673B51F3C5DQ36631019-3406CEB7-F332-4AD4-9F1C-87397A3C6F04Q36915096-FCCD8200-C70D-4D2C-8E51-9FF7331F41DEQ36933117-8E191952-D571-4399-A270-B3A414007E20Q37016637-7BE94B8E-99FD-4D98-A87A-7A2F4AD79D74Q37059104-07B01437-A84A-4597-9914-9B2C7B2BBEE4Q37146405-6DED0B6B-AA4E-4841-ABE9-CBC9A6C5E89FQ37364751-FE7C1B8D-C3C5-4B26-8368-5002089A2215Q37648626-F6B9CADF-3785-470A-8374-7E6A52CF2599Q38543002-3221BAEB-75F3-403A-A889-6B77D5F19C56Q39031126-DE3110FA-759E-404E-AA72-E94757AC70D3Q40254332-69AE967E-A582-4AA3-9316-C232E0A31D67Q40267696-C5501F53-4B3F-439B-8E51-01CA0BDC3FBAQ40352278-FA511235-4CD0-46E9-9547-F58D5B1D98F5Q40515306-019EC716-7A40-4607-8DE7-6A439CE7FFDDQ41281692-BF4AE831-9AB5-40CF-BE84-ECD919CCD6DFQ42004199-EB032D4B-9561-474A-B706-2735297D1865Q42320420-CD32EAF1-C1C7-4B1C-90E5-699C6EFC85D9Q42720826-56910AD8-833F-45D2-8124-A11B8714995BQ53714289-FA7F5F65-2270-47C8-A029-BA45383E5E01Q54239981-EAECE680-694D-4B50-91F0-2F9FFF140DCBQ55444694-07734800-A72B-46EC-8E02-8D1A8F7BAD0EQ56330067-3FC6D4A2-87E3-44C4-8263-0153A42E0D7CQ58720574-1E836478-EB85-4670-995B-8457DC8F87FF
P2860
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@ast
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@en
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@nl
type
label
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@ast
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@en
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@nl
prefLabel
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@ast
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@en
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@nl
P2860
P356
P1476
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients
@en
P2093
David Van Duin
Federico Perez
P2860
P304
P356
10.3949/CCJM.80A.12182
P577
2013-04-01T00:00:00Z